Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 568.38M | € 208.34M | € 213.57M | € 100.70M | € 114.74M |
Total Assets | € 2.17B | € 1.29B | € 1.35B | € 1.28B | € 1.33B |
Total Debt | € 55.90M | € 92.99M | € 123.61M | € 153.90M | € 179.95M |
Net Debt | € -512.48M | € -115.36M | € -89.96M | € 53.20M | € 65.21M |
Total Liabilities | € 593.72M | € 637.46M | € 739.34M | € 716.88M | € 729.85M |
Stockholders Equity | € 1.58B | € 653.07M | € 613.16M | € 566.50M | € 601.64M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |